Skip to main content
OpenTrials
Completed

NCT Number: NCT06502340

PERIOPERATIVE MYOCARDIAL DAMAGE IN ROBOT-ASSISTED SURGERY

Our study aimed to identify myocardial damage during or after robotic-assisted radical prostatectomy by measuring high-sensitive Troponin I levels, which are the most sensitive and effective according to the AHA/ACC guideline. The study's secondary objective was to establish which parameters were associated with myocardial damage.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Male

Study type

Observational

Primary location

Ankara Bilkent City Hospital

Ankara, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who will undergo elective robotic surgery
  • Patients with I, II, and III according to ASA classification
  • Those with body mass index (BMI) below 35kg/m2
  • Patients whose consent was obtained before the procedure

Exclusion criteria

  • Patients who were converted to open surgery for any reason
  • patients who did not agree to participate in the research

Treatment and study plan

high sensitive Troponin I

Diagnostic Test

high-sensitive Troponin I levels

Primary outcomes

  1. high-sensitive Troponin I levels

    Time frame: preoperative

  2. high-sensitive Troponin I levels

    Time frame: postoperative 24th hour

  3. high-sensitive Troponin I levels

    Time frame: postoperative 48th hour

Sponsors and collaborators

Lead sponsor

Ankara City Hospital Bilkent

Other

Registry information

Official study title

ASSESSMENT OF PERIOPERATIVE MYOCARDIAL DAMAGE IN ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMIES

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jul 16, 2024
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.